• 1
    Chung RT, Podolsky DK. Cirrhosis and its complications. In: IsselbacherKJ, BraunwaldE, WilsonJD, MartinJB, FauciAS, KasperDL, eds. Harrison's Principals of Internal Medicine. 15th ed. New York: McGraw-Hill, 2001;17541766.
  • 2
    Crawford JM. The liver and the biliary tract. In: CotranRS, KumarV, CollinsT, eds. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: Saunders, 1999;846891.
  • 3
    Kim WR, Brown RS Jr., Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36:227242.
  • 4
    Yanaga K, Tzakis AG, Shimada M, Campbell WE, Marsh JW, Stieber AC, Makowka L, et al. Reversal of hypersplenism following orthotopic liver transplantation. Ann Surg 1989; 210:180183.
  • 5
    Toghill PJ, Green S, Ferguson F. Platelet dynamics in chronic liver disease with special reference to the role of the spleen. J Clin Pathol 1977; 30:367371.
  • 6
    Martin TG 3rd, Somberg KA, Meng YG, Cohen RL, Heid CA, de Sauvage FJ, Shuman MA. Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation. Ann of Intern Med 1997; 127:285288.
  • 7
    Nagamine T, Ohtuka T, Takehara K, Arai T, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol 1996; 24:135140.
  • 8
    Hernandez F, Blanquer A, Linares M, Lopez A, Tarin F, Cervero A. Autoimmune thrombocytopenia associated with hepatitis C virus infection. Acta Haematol 1998; 99:217220.
  • 9
    Gordon MS, McCaskill-Stevens WJ, Battiato LA, Loewy J, Loesch D, Breeden E, Hoffman R, et al. A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996; 87:36153624.
  • 10
    Tepler I, Elias L, Smith JW 2nd, Hussein M, Rosen G, Chang AY, Moore JO, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996; 87:36073614.
  • 11
    Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology 1997; 202:116.
  • 12
    Hand D, Crowder MJ. Practical Longitudinal Data Analysis. Boca Raton, FL: CRC Press, 1996.
  • 13
    Teramura M, Kobayashi S, Yoshinaga K, Iwabe K, Mizoguchi H. Effect of interleukin 11 on normal and pathological thrombopoiesis. Cancer Chemother Pharmacol 1996; 38(Suppl):S99S102.
  • 14
    Zeldis JB, Boender PJ, Hellings JA, Steinberg H. Inhibition of human hemopoiesis by non-A, non-B hepatitis virus. J Med Virol 1989; 27:3438.
  • 15
    Pereira J, Accatino L, Alfaro J, Brahm J, Hidalgo P, Mezzano D. Platelet autoantibodies in patients with chronic liver disease. Am J Hematol 1995; 50:173178.
  • 16
    Bussel JB, Mukherjee R, Stone AJ. A pilot study of rhuIL-11 treatment of refractory ITP. Am J Hematol 2001; 66:172177.
  • 17
    Bozza M, Bliss JL, Maylor R, Erickson J, Donnelly L, Bouchard P, Dorner AJ, et al. Interleukin-11 reduces T-cell-dependent experimental liver injury in mice. Hepatology 1999; 30:14411447.
  • 18
    Trepicchio WL, Bozza M, Pedneault G, Dorner AJ. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996; 157:36273634.
  • 19
    Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, Satoh S, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994; 179:1529537.
  • 20
    Gabay C, Singwe M, Genin B, Meyer O, Mentha G, LeCoultre C, Vischer T, et al. Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liver. Clin Exp Immunol 1996; 105:260265.
  • 21
    Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, D'amico G, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001; 33:333338.
  • 22
    Artz AS, Ershler WB, Rustgi V. Interleukin-11 for thrombocytopenia associated with hepatitis C. J Clin Gastroenterol 2001; 33:425426.